Valuation: Ray Co., Ltd.

Market Cap 67.17B 50.09M 44.87M 41.39M 37.46M 70.05M 4.77B 71.18M 494M 197M 2.5B 188M 184M 7.91B P/E 2026 *
6.62x
P/E 2027 * 5.66x
Enterprise Value 122M 90.88K 81.4K 75.1K 67.96K 127K 8.65M 129K 896K 357K 4.53M 341K 334K 14.35M EV / Sales 2026 *
0.98x
EV / Sales 2027 * 0.73x
Free-Float
65.73%
Yield 2026 *
-
Yield 2027 * -
09-14 Graphy Inc. completed the acquisition of 15.35% stake in Ray Co., Ltd. from Lee Sang-cheol and Ray Holdings Co., Ltd. CI
09-09 Graphy Inc. signed of Share Transfer Agreement to acquire 15.35% stake in Ray Co., Ltd. from Lee Sang-cheol and Ray Holdings Co., Ltd. for KRW 28.9 billion. CI
12-22 Ray Co., Ltd. agreed to acquire LACHELLE for KRW 5 billion. CI
25-09-21 Ray Co., Ltd.(KOSDAQ:A228670) dropped from S&P Global BMI Index CI
24-03-26 Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co.,Ltd, L&C BIO Co.,LTD, Samsung Securities Co.,Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd. CI
24-03-24 Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co.,Ltd, L&C BIO Co.,LTD, Samsung Securities Co.,Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd. and other investors CI
23-05-12 Ray Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
21-04-21 Ray Co., Ltd. announced that it has received KRW 31.5 billion in funding CI
21-04-19 Ray Co., Ltd. announced that it expects to receive KRW 31.5 billion in funding CI
20-11-18 Optical Biosystems, Inc. announced that it has received $20 million in funding from a group of investors CI
19-12-23 Ray Co., Ltd.(KOSDAQ:A228670) added to S&P Global BMI Index CI
19-12-23 Ray Co., Ltd.(KOSDAQ:A228670) added to S&P Global BMI Index CI
19-08-07 Ray Co., Ltd. has completed an IPO in the amount of KRW 20 billion. CI
1 day-2.16%
1 week-3.91%
Current month-2.16%
1 month-0.69%
3 months+9.01%
6 months-54.69%
Current year-36.56%
1 week 4,175
Extreme 4175
4,495
1 month 4,110
Extreme 4110
4,675
Current year 3,680
Extreme 3680
11,690
1 year 3,680
Extreme 3680
11,690
3 years 3,680
Extreme 3680
25,700
5 years 3,680
Extreme 3680
42,150
10 years 3,680
Extreme 3680
42,150
Manager TitleAgeSince
Chief Executive Officer 53 2014-12-31
Director of Finance/CFO - -
Chief Operating Officer - 2024-10-16
Director TitleAgeSince
Director/Board Member 53 2014-12-31
Director/Board Member 57 2022-03-27
Director/Board Member 57 2024-10-16
Date Insider Type Main position Quantity % Market Cap. Importance
4/14/25 Buy 1,000 0.0064%
4/1/25 Buy 500 0.0032%
4/1/25 Buy 500 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
-2.16%-3.91%-21.48%-79.10% 50.09M
+0.71%+4.82%+27.02%+64.39% 262B
+1.24%+3.15%+10.73%+26.13% 167B
+1.03%+1.11%-16.52%+73.28% 156B
+0.61%-7.22%-57.44%-13.79% 61.87B
+2.90%+4.83%+14.21%+53.04% 54.44B
+0.70%+2.71%-13.09%-6.48% 53.3B
-2.35%-3.79%+8.26%+63.75% 50.25B
-0.18%+4.18%+26.50%+76.27% 51.07B
+0.67%+5.37%+39.77%+96.14% 47.17B
Average +0.22%+1.20%+1.80%+35.36% 90.26B
Weighted average by Cap. +0.71%+2.44%+7.17%+50.91%

Financials

2026 *2027 *
Net sales 124B 92.56M 82.9M 76.48M 69.21M 129M 8.81B 132M 912M 364M 4.61B 347M 340M 14.61B 147B 110M 98.18M 90.58M 81.97M 153M 10.44B 156M 1.08B 431M 5.46B 411M 403M 17.3B
Net income 10.89B 8.12M 7.28M 6.71M 6.07M 11.36M 774M 11.54M 80.08M 31.95M 405M 30.49M 29.84M 1.28B 13.07B 9.75M 8.73M 8.06M 7.29M 13.63M 928M 13.85M 96.12M 38.35M 486M 36.59M 35.81M 1.54B
Net Debt 54.7B 40.79M 36.54M 33.71M 30.5M 57.04M 3.88B 57.96M 402M 160M 2.03B 153M 150M 6.44B 40.77B 30.4M 27.23M 25.12M 22.73M 42.51M 2.89B 43.19M 300M 120M 1.52B 114M 112M 4.8B
Projected Income Statement - Annual - Ray Co., Ltd.
Logo Ray Co., Ltd.
Ray Co Ltd is a Korea-based company principally engaged in the manufacturing of dental medical device equipment business. The Company operates its business through two segments. The Digital Therapy Solutions segment is engaged in providing digital therapy solutions and three-dimensional (3D) form printer solutions. The Digital Diagnostic Systems segment is engaged in the manufacture and sale of medical devices such as pano imaging devices and ceph imaging devices. The Company sells its products in domestic and overseas markets.
Employees
163
Date Price Change Volume
26-10-29 ₩4,295.00 -2.16% 18,556
26-10-28 ₩4,390.00 +0.46% 17,017
26-10-27 ₩4,370.00 -0.46% 12,013
26-10-26 ₩4,390.00 -1.01% 27,382
26-10-23 ₩4,435.00 -0.78% 18,029
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Ray Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
4,295.00KRW
Average target price
12,500.00KRW
Spread / Average Target
+191.04%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ray Co., Ltd.
  1. Stock Market
  2. Stocks
  3. A228670 Stock